Spain: new stem cell R&D (research and development) blow
This article was originally published in Clinica
Executive Summary
The Spanish governing Partido Popular party has succeeded in rejecting a bill proposed by the main opposition party, the PSOE, to allow embryonic stem cell research for therapeutic purposes. The PSOE was calling on the government to allow the use of embryos stored for IVF for longer than the prescribed five-year limit, as proposed by the European Science Foundation. There are an estimated 40,000 embryos that fall in this category. The main stumbling block in the debate is the method by which the stem cells might be obtained, ie by using embryos left over from IVF treatment storage, or by "cloning" embryos for research purposes.
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.